Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
40,53 € ↓ -2,45 (-5,70%)
2026-06-05
DEL PRIS
SecurityDE:12V / Veracyte, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership15,759 shares
Latest Disclosed Value $ 507,598
ProShare Advisors LLC reports 15.92% decrease in ownership of 12V / Veracyte, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 15,759 shares of Veracyte, Inc. (DE:12V) valued at $419,189 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 18,743 shares of Veracyte, Inc.. This represents a change in shares of -15.92% during the quarter. The current value of the position is $638,712 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F VERACYTE COM 92337F107 15,759 -2,984 -15.92 508 -35.74 0.0008
2026-02-06 2025-12-31 13F VERACYTE COM 92337F107 18,743 1,168 6.65 789 30.85 0.0014
2025-11-06 2025-09-30 13F VERACYTE COM 92337F107 17,575 -1,422 -7.49 603 17.54 0.0013
2025-08-07 2025-06-30 13F VERACYTE COM 92337F107 18,997 -1,384 -6.79 513 -15.07 0.0010
2025-05-08 2025-03-31 13F VERACYTE COM 92337F107 20,381 -4,930 -19.48 604 -39.72 0.0014
2025-02-14 2024-12-31 13F VERACYTE COM 92337F107 25,311 6,251 32.80 1,002 54.63 0.0023
2024-11-14 2024-09-30 13F VERACYTE COM 92337F107 19,060 4,590 31.72 649 107.03 0.0016
2024-08-13 2024-06-30 13F VERACYTE COM 92337F107 14,470 -3,872 -21.11 314 -22.91 0.0008
2024-05-08 2024-03-31 13F VERACYTE COM 92337F107 18,342 1,625 9.72 406 -11.55 0.0011
2024-02-14 2023-12-31 13F VERACYTE COM 92337F107 16,717 2,505 17.63 460 44.79 0.0014
2023-11-13 2023-09-30 13F VERACYTE COM 92337F107 14,212 58 0.41 317 -11.94 0.0010
2023-08-10 2023-06-30 13F VERACYTE COM 92337F107 14,154 -49 -0.34 361 13.92 0.0010
2023-05-26 2023-03-31 13F/A-1 VERACYTE COM 92337F107 14,203 -952 -6.28 317 -11.98 0.0010
2023-05-12 2023-03-31 13F VERACYTE COM 92337F107 14,203 -952 317 0.0010
2023-02-02 2022-12-31 13F VERACYTE COM 92337F107 15,155 1,234 8.86 360 55.41 0.0013
2022-11-07 2022-09-30 13F VERACYTE COM 92337F107 13,921 307 2.26 231 -14.44 0.0009
2022-08-01 2022-06-30 13F VERACYTE COM 92337F107 13,614 -6,407 -32.00 270 -51.09 0.0009
2022-05-10 2022-03-31 13F VERACYTE COM 92337F107 20,021 -4,710 -19.04 552 -45.88 0.0012
2022-02-08 2021-12-31 13F VERACYTE COM 92337F107 24,731 945 3.97 1,020 -7.69 0.0020
2021-11-12 2021-09-30 13F VERACYTE COM 92337F107 23,786 -5,802 -19.61 1,105 -6.59 0.0031
2021-08-13 2021-06-30 13F VERACYTE COM 92337F107 29,588 2,613 9.69 1,183 -18.41 0.0035
2021-05-14 2021-03-31 13F VERACYTE COM 92337F107 26,975 5,350 24.74 1,450 37.05 0.0046
2021-02-09 2020-12-31 13F VERACYTE COM 92337F107 21,625 5,485 33.98 1,058 101.91 0.0039
2020-11-13 2020-09-30 13F VERACYTE COM 92337F107 16,140 1,347 9.11 524 36.81 0.0024
2020-08-03 2020-06-30 13F VERACYTE COM 92337F107 14,793 5,307 55.95 383 65.80 0.0020
2020-05-15 2020-03-31 13F VERACYTE COM 92337F107 9,486 -7,471 -44.06 231 -51.16 0.0017
2020-02-12 2019-12-31 13F VERACYTE COM 92337F107 16,957 -1,533 -8.29 473 6.53 0.0022
2019-11-12 2019-09-30 13F VERACYTE COM 92337F107 18,490 1,736 10.36 444 -7.11 0.0025
2019-08-13 2019-06-30 13F VERACYTE COM 92337F107 16,754 -286 -1.68 478 12.21 0.0029
2019-05-15 2019-03-31 13F VERACYTE COM 92337F107 17,040 291 1.74 426 101.90 0.0025
2019-02-14 2018-12-31 13F VERACYTE COM 92337F107 16,749 -2,797 -14.31 211 12.83 0.0015
2018-11-14 2018-09-30 13F VERACYTE COM 92337F107 19,546 1,927 10.94 187 13.33 0.0013
2018-08-13 2018-06-30 13F VERACYTE COM 92337F107 17,619 -1,264 -6.69 165 57.14 0.0011
2018-05-14 2018-03-31 13F VERACYTE COM 92337F107 18,883 -2,971 -13.59 105 -26.57 0.0007
2018-02-14 2017-12-31 13F VERACYTE COM 92337F107 21,854 21,854 143 0.0010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.